ALPHACORE PHARMA
ALPHACORE PHARMA
Industry:
Pharmaceutical
Founded:
2007-01-01
Address:
Ann Arbor, Michigan, United States
Country:
United States
Website Url:
http://www.alphacorepharma.com
Status:
Active
Contact:
734-527-9137
Similar Organizations
Altum Pharmaceuticals
Altum Pharmaceuticals operates as a biopharmaceutical company.
INIM Pharma AB
INIM Pharma operates as a bio-pharmaceutical company.
Official Site Inspections
http://www.alphacorepharma.com
Unable to get host informations!!!
More informations about "AlphaCore Pharma"
AlphaCore Pharma - Crunchbase Company Profile & Funding
AlphaCore Pharma operates as a biopharmaceutical company. New. Resources. Advanced Search. Start Free Trial ... Experience the new Crunchbase, powered by AI . Experience the …See details»
AlphaCore Pharma 2025 Company Profile: Valuation, …
AlphaCore Pharma General Information Description. Manufacturer of drugs and pharmaceuticals for reducing cholesterol levels. The company develops ACP-501, a recombinant human lecithin-cholesterol acyltransferase (LCAT) …See details»
AlphaCore Pharma - Ownership and Business Overview - Mergr
Apr 3, 2013 AlphaCore Pharma was founded in 2007. Life Science M&A Summary in 2013 Out of 60 sectors in the Mergr database, life science ranked 8 in number of deals in 2013 .See details»
ALPHACORE PHARMA, LLC - VentureRadar
Dec 31, 2010 Amount: $1,254,300.00 | Treatment of Acute Coronary Syndromes with Recombinant LCAT InfusionSee details»
AlphaCore Pharma - 2025 Company Profile - Tracxn
AlphaCore Pharma is an acqui-hired company based in Ann Arbor (United States), founded in 2007. It operates as a Protein therapeutics for the treatment of cardiovascular diseases such …See details»
AstraZeneca's MedImmune unit acquires AlphaCore Pharma
Apr 3, 2013 AstraZeneca announced that MedImmune, its global biologics research and development unit, has acquired AlphaCore Pharma, an Ann Arbor, Michigan-based …See details»
MedImmune, AstraZeneca’s biologics unit, acquires AlphaCore …
Apr 3, 2013 AstraZeneca announced that MedImmune has acquired AlphaCore Pharma, an Ann Arbor, Michigan-based biotechnology company... Recommended Discover how a well …See details»
AlphaCore Pharma LLC - Company Profile and News
Company profile page for AlphaCore Pharma LLC including stock price, company news, executives, board members, and contact informationSee details»
AlphaCore Pharma LLC - Drug pipelines, Patents, Clinical trials
Explore AlphaCore Pharma LLC with its drug pipeline, therapeutic area, technology platform, 1 clinical trial, and 4 literature.See details»
AlphaCore Pharma Company Profile, Financial and Strategic
DigitGaps report on AlphaCore Pharma delivers a detailed in-depth and comprehensive insights of the company, its history, corporate strategy, its businesses and structures, and company …See details»
AlphaCore Pharma - Products, Competitors, Financials, Employees ...
AlphaCore Pharma is developing ACP-501 (rhLCAT) for the treatment of the orphan disease familial LCAT deficiency (FLD) and for the acute treatment of atherosclerosis. In April 2013, …See details»
MedImmune acquires Ann Arbor start-up AlphaCore Pharma
MedImmune has acquired Ann Arbor-based AlphaCore Pharma, creating another exit for a local up-and-coming start-up. MedImmune, the global biologics research and development arm of …See details»
MedImmune acquires AlphaCorePharma - Nordic Life Science
Apr 29, 2013 AstraZeneca’s global biologics R&D arm MedImmune has acquired AlphaCorePharma. The Michigan-based biotech company focuses on the development of …See details»
AlphaCore Pharma - Raised Funding from 1 investor - Tracxn
Feb 22, 2025 Demuzo - Bali based, raised a funding of $600K in Seed round held on Feb 21, 2025.; Pulsetto - Vilnius based, raised a funding of $2.09M in Seed round held on Feb 21, …See details»
MedImmune, AstraZeneca's biologics unit, acquires AlphaCore …
AstraZeneca today announced that MedImmune, its global biologics research and development unit, has acquired AlphaCore Pharma, an Ann Arbor, Michigan-based biotechnology company …See details»
AlphaCore Pharma - CB Insights
Explore {AlphaCore Pharma's key management people. Discover current leadership team members including founders, CEO, other executives and board directors. AlphaCore Pharma …See details»
AstraZeneca plc : MedImmune, AstraZeneca’s biologics unit, …
Apr 3, 2013 AstraZeneca today announced that MedImmune, its global biologics research and development unit, has acquired AlphaCore Pharma, an Ann Arbor, Michigan-based …See details»
AstraZeneca Unit Acquires AlphaCore Pharma
Apr 3, 2013 AstraZeneca’s MedImmune unit has acquired AlphaCore Pharma, a privately held U.S. biotechnology company developing a new type of cholesterol medicine.Financial details …See details»
AlphaCore Pharma - CB Insights
See AlphaCore Pharma funding rounds, investors, investments, exits and more. Evaluate their financials based on AlphaCore Pharma's post-money valuation and revenue. AlphaCore …See details»
AstraZeneca loses US patent; MedImmune buys AlphaCore
Mar 13, 2025 AstraZeneca loses patent protection for its asthma medicine in the United States, while its R&D unit MedImmune continues the company’s cardiovascular focus with the …See details»